IPHA Competitors & Alternatives
Compare Innate Pharma with similar stocks in the same industry
Biotechnology
IPHA
Main Stock$1.79
Tradestie Score
54
Market Cap
$182.31M
Revenue Growth
-0.5%
Analyst Upside
+235.2%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$12.39
|
$211.22M | - | 62 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$5.00
|
$202.58M | - | 56 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$18.20
|
$170.45M | - | 54 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.02
|
$158.43M | - | 55 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$27.19
|
$154.27M | - | 54 | Compare |
|
CCCC
C4 Therapeutics, Inc.
|
$4.26
|
$153.02M | - | 58 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$13.08
|
$133.50M | - | 56 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.44
|
$114.01M | - | 53 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$27.04
|
$110.20M | - | 60 | Compare |
More IPHA Analysis
Data updated: Jun 27, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry